HCW Biologics Inc. Share Price
NASDAQ: HCWB | Micro CapHCW Biologics Inc. Stock Performance
HCW Biologics Inc. Share Price Chart
HCW Biologics Inc. Quarterly Profit & Loss
All figures in USD
HCW Biologics Inc. Annual Profit & Loss
All figures in USD
About HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
HCW Biologics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.71 | $1.21 | -33.97% |
Sep 2026 | $3.46 | $1.82 | -41.69% |
Aug 2026 | $3.95 | $3.13 | -4.86% |
Jul 2026 | $4.58 | $3.29 | -34.98% |
Jun 2026 | $2.03 | $5.06 | +153.00% |
May 2026 | $0.45 | $2.00 | +330.11% |
Apr 2026 | $0.33 | $0.47 | +34.78% |
Mar 2026 | $0.54 | $0.34 | -37.61% |
Feb 2026 | $1.14 | $0.55 | -50.84% |
Jan 2026 | $0.98 | $1.13 | +13.64% |
Dec 2025 | $2.07 | $0.99 | -52.86% |
Nov 2025 | $3.30 | $2.10 | -46.70% |